GGrantIndex
← Leaderboards

Touro University Of California

Vallejo, CA

Compare ↔
$16,473,140
Total funding
18
Grants

Funding over time

peak $1.5M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$16,473,140 · 18

By mechanism

R01$13,277,269 · 7
R21$2,438,371 · 8
R15$612,800 · 2
R03$144,700 · 1

Investigators at Touro University Of California

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Emerging Leaders

6–10 yrs in

Not enough data

Largest grants

Metabolic impact of fructose restriction in obese children$741,779
R01 · FY2010 · DK
Fructose Metabolism Effects on the Liver: Unraveling the Role of Defective Intestinal GNG in Individuals with Obesity$730,498
R01 · FY2025 · DK
Fructose: Substrate, Stimulus, or Both?$714,999
R01 · FY2022 · DK
Fructose: Substrate, Stimulus, or Both?$714,999
R01 · FY2020 · DK
Fructose: Substrate, Stimulus, or Both?$714,999
R01 · FY2019 · DK
Fructose: Substrate, Stimulus, or Both?$714,999
R01 · FY2023 · DK
Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency$623,638
R01 · FY2013 · HL
Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency$616,825
R01 · FY2017 · HL
Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency$613,174
R01 · FY2016 · HL
Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency$607,272
R01 · FY2015 · HL
Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency$604,426
R01 · FY2014 · HL
Metabolic impact of fructose restriction in obese children$563,771
R01 · FY2011 · DK
Metabolic impact of fructose restriction in obese children$535,277
R01 · FY2012 · DK
Metabolic impact of fructose restriction in obese children$506,343
R01 · FY2014 · DK
Metabolic impact of fructose restriction in obese children$501,437
R01 · FY2013 · DK
Cannabinoid Signaling Interactions During Axon Development in situ$364,250
R15 · FY2023 · DA
De novo lipogenesis in the pathogenesis of non-alcoholic fatty liver disease$350,924
R01 · FY2009 · DK
De novo lipogenesis in the pathogenesis of non-alcoholic fatty liver disease$347,102
R01 · FY2008 · DK
De novo lipogenesis in the pathogenesis of non-alcoholic fatty liver disease$334,752
R01 · FY2007 · DK
Extra-hepatic postprandial metabolism of dietary fructose$320,540
R01 · FY2022 · DK